This study focuses on patients with Intra-Abdominal Candidiasis, which is a fungal infection that occurs inside the abdomen. The research examines a medication called Rezafungin, which is given through intravenous infusion (delivered directly into a vein). This medicine belongs to a group of drugs used to treat fungal infections.
The study aims to understand how Rezafungin spreads through the body, particularly how it moves between the blood and the fluid in the abdomen. The medication will be given to patients who have signs of infection in their abdomen that hasn’t improved with other treatments. Patients will receive the medicine through an infusion into their vein, and samples will be collected from both their blood and abdominal fluid.
During the study, doctors will monitor how well the medication works against common types of fungi, specifically Candida albicans and Candida glabrata. They will also track the patients’ recovery and any changes in their condition. The treatment period may last up to 4 weeks, during which various measurements and observations will be made to evaluate the effectiveness of the medication.
Spain 
